Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.

Hou ZQ, Sun ZX, Su CY, Tan H, Zhong X, Hu B, Zhou Y, Shang DY.

Cardiovasc Ther. 2013 Apr;31(2):108-14. doi: 10.1111/1755-5922.12001.

PMID:
23490237
2.
3.

Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.

Zemljic G, Bunc M, Yazdanbakhsh AP, Vrtovec B.

J Card Fail. 2007 Aug;13(6):417-21.

PMID:
17675054
4.

Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.

Oner E, Erturk M, Birant A, Kurtar Mansıroglu A, Akturk IF, Karakurt H, Yalcin AA, Uzun F, Somuncu MU, Yildirim A.

Cardiol J. 2015;22(1):87-93. doi: 10.5603/CJ.a2014.0044. Epub 2014 May 20.

PMID:
24846511
5.

Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.

Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.

Am J Cardiol. 2006 Jul 1;98(1):102-6. Epub 2006 May 6.

PMID:
16784930
6.

Short-term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure.

Kurt IH, Yavuzer K, Batur MK.

Heart Vessels. 2010 Sep;25(5):392-9. doi: 10.1007/s00380-009-1216-4. Epub 2010 Jul 31.

PMID:
20676961
7.

Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure.

Lilleberg J, Laine M, Palkama T, Kivikko M, Pohjanjousi P, Kupari M.

Eur J Heart Fail. 2007 Jan;9(1):75-82. Epub 2006 Jul 7.

8.

Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.

Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W.

Circulation. 2000 Oct 31;102(18):2222-7.

9.

Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.

Duygu H, Turk U, Ozdogan O, Akyuz S, Kirilmaz B, Alioglu E, Gunduz R, Bozkaya YT, Turkoglu C, Payzin S.

Cardiovasc Ther. 2008 Fall;26(3):182-8. doi: 10.1111/j.1755-5922.2008.00050.x.

PMID:
18786088
10.

Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.

Duman D, Palit F, Simsek E, Bilgehan K, Sacide A.

Can J Cardiol. 2009 Oct;25(10):e353-6.

11.

Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.

Cohen-Solal A, Logeart D, Huang B, Cai D, Nieminen MS, Mebazaa A.

J Am Coll Cardiol. 2009 Jun 23;53(25):2343-8. doi: 10.1016/j.jacc.2009.02.058.

12.

Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.

Flevari P, Parissis JT, Leftheriotis D, Panou F, Kourea K, Kremastinos DT.

Am J Cardiol. 2006 Dec 15;98(12):1641-5. Epub 2006 Oct 25.

PMID:
17145226
13.

Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.

Nieminen MS, Cleland JG, Eha J, Belenkov Y, Kivikko M, Põder P, Sarapohja T.

Eur J Heart Fail. 2008 Dec;10(12):1246-54. doi: 10.1016/j.ejheart.2008.09.006. Epub 2008 Oct 21.

14.

Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience.

Parle NM, Thomas MD, Dembo L, Best M, Driscoll GO.

Heart Lung Circ. 2008 Jun;17(3):206-10. doi: 10.1016/j.hlc.2007.10.014. Epub 2008 Jan 31.

PMID:
18242130
15.

[The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].

Paksoy F, Ulaş T, Tursun I, Dal MS, Oztekin E, Borlu F.

Anadolu Kardiyol Derg. 2012 Feb;12(1):16-22. doi: 10.5152/akd.2012.004. Epub 2012 Jan 4. Turkish.

16.

Value of IGF-I levels in the evaluation of response to treatment with levosimendan in patients with severe heart failure.

Işık S, Cetin M, Ciçekçioğlu H, Uçar O, Çetin ZG, Ozuğuz U, Bakır F, Berker D, Güler S.

Anadolu Kardiyol Derg. 2011 Sep;11(6):523-9. doi: 10.5152/akd.2011.137. Epub 2011 Aug 8.

17.

Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up.

Sargento L, Brito D, Matias JS, Madeira H.

Rev Port Cardiol. 2007 Jul-Aug;26(7-8):717-26. English, Portuguese.

18.

Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.

Ponschab M, Hochmair N, Ghazwinian N, Mueller T, Plöchl W.

Eur J Anaesthesiol. 2008 Aug;25(8):627-33. doi: 10.1017/S0265021508004080. Epub 2008 Apr 11.

PMID:
18405408
19.

Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.

Branzi G, Malfatto G, Villani A, Ciambellotti F, Revera M, Giglio A, Rosa FD, Facchini M, Parati G.

J Cardiovasc Med (Hagerstown). 2010 Sep;11(9):662-8. doi: 10.2459/JCM.0b013e32833832f6.

PMID:
20613551
20.

The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure.

Cetin M, Uçar O, Cicekçioğlu H, Güven Cetin Z, Sahin M, Vasfi Ulusoy F, Aydoğdu S.

Acta Cardiol. 2012 Jun;67(3):317-23.

PMID:
22870740

Supplemental Content

Support Center